Hypertension Elizabeth Evans DNP Renal Medicine Associates 2/29/2020

Page created by Guy Chavez
 
CONTINUE READING
Hypertension Elizabeth Evans DNP Renal Medicine Associates 2/29/2020
Hypertension
Elizabeth Evans DNP
Renal Medicine Associates
2/29/2020
Hypertension Elizabeth Evans DNP Renal Medicine Associates 2/29/2020
 Define normal blood pressure, elevated blood pressure and stages
               of hypertension
              Identify risk factors for hypertension
Objectives    Describe the treatment approaches for elevated hypertension,
               including lifestyle modifications and medication therapy

              I have no conflicts of interest to disclose
Hypertension Elizabeth Evans DNP Renal Medicine Associates 2/29/2020
 Hypertension is the most common chronic disease among adults
               in the world.
              Identified as the leading risk factor for premature death, disability
               and overall disease burden worldwide.
              Each increase of 20mm Hg in the systolic BP or 10 mm Hg in the
Prevalence     diastolic BP doubles the risk of death from stroke or heart disease.
              Most patients with hypertension could lower their BP through
               lifestyle changes.
              To diagnose hypertension, BP readings should use the average of
               2 or more careful BP measurements taken on > 2 occasions using
               careful BP measurement technique.
Hypertension Elizabeth Evans DNP Renal Medicine Associates 2/29/2020
 Step 1 – Properly prepare the patient (sit in chair, feet on floor and
                  back supported for > 5 minutes; avoid caffeine, exercise &
                  smoking for at least 30 minutes; ensure patient has voided; no
                  talking; ensure BP cuff will go on skin (not clothing); do not take
                  while patient on exam table).
                 Step 2 – Use proper BP measurement technique (calibrated BP
Key Steps for     cuff; support patient’s arm; apply BP cuff on upper arm at the
                  level of the right atrium (sternum mid-point).
Proper BP        Step 3 – Proper measurement (1st visit – measure both arms – use
Measurement       the arm with the higher reading; separate repeat measurements
                  by 1-2 minutes; for auscultation – listen for Korotkoff sounds).
Checklist        Step 4 – Proper documentation – note time of BP Rx.
                 Step 5 – Average the readings – use an average of > 2 readings
                  obtained on > 2 occasions to estimate the patient’s BP.
                 Step 6 – Provide the patient the BP readings both in writing and
                  verbally.
Hypertension Elizabeth Evans DNP Renal Medicine Associates 2/29/2020
Arm Size/Circumference (measure arm at bicep    Appropriate Cuff Size
                 level or half-way between elbow and shoulder)

                 22-26 cm (8.6 to 10.2 inches)                   Small adult

                 27 – 34 cm (10.3 to 13.4 inches)                Adult
Proper BP cuff
                 34 – 44 cm (13.5 to 17.3 inches)                Large Adult
size based on
arm size         45 – 52 cm ( 17.4 to 20.4 inches)               Adult Thigh

                              https://www.youtube.com/watch?v=-BCDM4i3Cho
Hypertension Elizabeth Evans DNP Renal Medicine Associates 2/29/2020
Primary Hypertension               Secondary Hypertension
                 Gradual increase in BP with slow   BP lability, episodic pallor and dizziness
                 rate of rise in BP.                (pheochromocytoma)
                 Lifestyle factors that favor higher Muscle cramps, weakness (hypokalemia
                 BP (weight gain, high-sodium diet, from primary aldosteronism or secondary
Primary versus   decreased activity, job change      aldosteronism due to renovascular disease)
                 with increased travel, excessive
Secondary        alcohol intake).
Hypertension-    Family history of hypertension     Snoring, hypersomnolence (OSA)
                                                    Prostatism (CKD due to post-renal urinary
How to                                              obstruction)
recognize the                                       Edema, fatigue, anemia (kidney disease)
                                                    History of coarctation repair (residual HTN
differences                                         associated with coarctation)
                                                    Absence of family history of HTN
                                                    Medication or substance abuse (alcohol,
                                                    NSAIDs, cocaine, amphetamines)
                                                    Central obesity, easy bruising, facial
                                                    rounding (Cushings syndrome)
ACC/AHA          Systolic BP in mm       Diastolic BP in         Treatment Plan
                                      2017             Hg                      mm Hg
                                      guideline
                                      definition
                                      Normal            100                   Lifestyle changes
                                      Hypertension                                                     and 2 or more
                                                                                                       antihypertensive
                                                                                                       medications
 Whelton et al, 2017 American College of Cardiology/American Heart Association High Blood Pressure Clinical Practice Guidelines.
 Office BP measurements are often not accurate; recommend to
                     diagnose and follow-up using home BP measurements (HBPM) or
                     ambulatory BP measurements (ABPM).
                    Examples of inaccurate readings: white coat HTN and masked
                     HTN and see the difference:
                    BP Classification   Office BP           Daytime ABPM or HBPM
Office versus       Normal BP            130/80 mm Hg

                    White Coat HTN      > 130/80 mm Hg      < 130/80 mm Hg

                    Masked HTN          130/80 mm Hg        > 130/80 mm Hg
Healthy Diet – Dietary approaches to     Diet rich in fruits, vegetables, whole
                Stop HTN (DASH diet).                    grains low fat dairy products with total
                                                         reduced fat intake.
                Weight loss – focus on losing weight.    Ideal body weight – 1 mm Hg BP
                                                         decrease for every 1kg body weight loss.
Lifestyle       Sodium – reduce dietary sodium intake    Attempt to lower sodium intake by 1000
                to
Stop Nicotine
                  • cigarettes and e-cigarettes
                  • dipping and chewing tobacco
                  • remember to provide stop smoking resources
                  • avoid 2nd hand smoke
                  • ask if they are willing to stop smoking every visit

Other Lifestyle   Restrict medications that increase BP:
                  • Non-steroidal anti-inflammatories (NSAIDs),
changes           • caffeine
                  • decongestants
                  • some herbal supplements
                  • oral contraceptives
                  • recreational drugs
                  • angiogenesis or tyrosine kinase inhibitors
                  • amphetamines
                  • some antidepressants

                  Adapted from Whelton et al, 2017 ACC/AHA High Blood Pressure
                  Clinical Practice Guidelines
Food Group                              Number of Servings Daily
                 Grains and grain products               7 or 8

                 Vegetables                              4 or 5
DASH diet –
Dietary          Fruits                                  4 or 5

Approaches to    Low-fat or fat-free dairy foods         2 or 3
Stop
                 Lean meat, fish and poultry
Primary Agent/Class               Drug
               Thiazide or Thiazide-like drugs   Chlorthalidone,
                                                 Hydrochlorothiazide, Indapamide

               ACE Inhibitors (Angiotensin       Benazapril, Captropril, Enalapril,
               Converting Enzyme Inhibitors)     Fosinopril, Lisinopril, Moexipril,
Oral Anti-                                       Perindopril, Quinapril, Ramipril,
hypertensive                                     Trandolaprils (the prils)

Medications-   ARBS (Angiotensin Receptor        Azilsartan, Candesartan, Eprosartan,
               Blockers)                         Losartan, Irbesartan, Olmesartan,
Primary                                          Telmisartan, Varsartan (the sartans)
Agents         CCBs (Calcium Channel Blockers)   Amlodipine, Felodipine, Isradipine,
               dihydropyrdines -- CCB-D          Nisoldipine, Nicardipine SR,
                                                 Nifedipine LA

               CCBs (Calcium Channel Blockers)   Diltiazem ER, Verapamil ER, Verapil
               nondihydropyridines – CCB-ND      SR, Verapamil – delayed onset
Secondary Agents                             Drugs
               Loop Diuretics                               Bumetanide, Furosemide, Torsemide
               Potassium Sparing Diuretics                  Amiloride, Triamterene
               Aldosterone Antagonists Diuretics (MRAs)     Eplerenone, Spironolactone
               Cardioselective Beta Blockers                Atenolol, Betaxolol, Bisoprolol,
Oral Anti-                                                  Metoprolol tartrate and succinate

hypertensive   Cardioselective/vasodilatory Beta Blockers   Nebivolol
               Noncardioselective Beta Blockers             Nadolol, Propranol IR and LA
Agents –       Beta Blockers – intrinsic sympathomimetic    Acebutolol, Penbutolol, Pindolol
Secondary      activity

Agents         Alpha & Beta receptor Beta Blockers          All Carvedilols, Labetalol
               Direct renin inhibitor DRI)                  Aliskiren
               Alpha-1 Blockers                             Doxazosin, Prazosin, Terazosin
               Central Alpha-agonist & other centrally      Clonidine (oral/patch), Methyldopa,
               acting drugs                                 Guanfacine
               Central Vasolidators                         Hydralazine, Minoxidil
Co-morbid Disease            First Line Drugs                    Other Drugs to
                                                                                   add or avoid
                  Ischemic heart disease       MI/Angina - BBs, CCB-D              Thiazides, MRAs.
                  Heart Failure with reduced   ACEi, ARBs, MRA; diuretic; AR-      CCB-ND are not
First Line        ejection fraction            neprilysin inhibitor-ARB med; BB
                                               (carvedilol, bisoprolol, metoprol
                                                                                   recommended
                                                                                   Do Not combine
Drugs for                                      ol succinate).                      ACE and ARBs.
                  Heart Failure with          Diuretics; Chlorthalidone – HTN      Avoid CCBs-ND
Hypertension      preserved ejection fraction control HTN due to fluid mgmt.
based             Chronic Kidney Disease     ACEi; use ARB if intolerant to
                  (CKD) or Kidney Transplant ACEi.
on comorbid       Diabetes                     Diuretics; CCBs, ACEi; ARBs
diseases or       Atrial Fibrillation          BB (rate and BP control).

special patient   Metabolic Syndrome
                  Pregnancy
                                               Weight loss, exercise. ?drug
                                               Methylodopa, Nifedipine,
                                                                                   Caution thiazides
                                                                                   BB or CCBs appear
groups                                         Labetalol. Stop ACEi/ARB/DRI        to prevent pre-
                                               due to fetal abnormalities.         eclampsia.
                  Black adults without heart   Thiazides, CCBs; >2 meds are        Lifestyle changes
                  failure or CKD               recommended to achieve
 Some of these drugs may decrease your body's supply of the mineral
                  potassium. Symptoms such as weakness, leg cramps or being tired
                  may result. Eating foods containing potassium may help prevent
                  significant potassium loss. If your doctor recommends it, you could
                  prevent potassium loss by taking a liquid or tablet that has potassium
                  along with the diuretic. Diuretics such as amiloride (Midamar)*,
                  spironolactone (Aldactone)* or triamterene (Dyrenium)* are called
Diuretic          "potassium sparing" agents. They don't cause the body to lose
                  potassium. They might be prescribed alone, but are usually used with
                  another diuretic. Some of these combinations are Aldactazide*,
possible side     Dyazide*, Maxzide* or Moduretic*.
effects:         Some people suffer from attacks of gout after prolonged treatment
                  with diuretics. This side effect isn't common and can be managed by
                  other treatment.
                 People with diabetes may find that diuretic drugs increase their blood
                  sugar level. A change in medication, diet, insulin or oral anti-diabetic
                  dosage corrects this in most cases.
                 Impotence may occur.
 Insomnia
                 Cold hands and feet
                 Tiredness or depression
                 Slow heartbeat
                 Symptoms of asthma
Possible Beta    Impotence may also occur
Blocker Side     If you have diabetes and you're taking insulin, have your responses
Effects           to therapy monitored closely.
                 If you have been prescribed beta-blockers, consult your healthcare
                  provider prior to conception if you are considering pregnancy or if
                  there is a chance you could become pregnant. If you discover that
                  you are pregnant consult your healthcare provider as soon as
                  possible to determine the safest medication for you at this time.
 Skin rash
                 Loss of taste
                 Chronic dry, hacking cough
Possible Ace     In rare instances, kidney damage
                 Women who are taking ACE inhibitors or ARBs for high blood pressure
Inhibitors or     should not become pregnant while on this class of drugs. If you're
                  taking an ACE inhibitor or an ARB and think you might be pregnant,
Angiotensin       see your doctor immediately. These drugs have been shown to be
                  dangerous to both mother and baby during pregnancy. They can
Receptor          cause low blood pressure, severe kidney failure, excess
                  potassium (hyperkalemia) and even death of the newborn.
Blocker Side     May cause occasional dizziness.
Effects          ARBs should not be used during pregnancy.Medications that act
                  directly on the renin-angiotensin system can cause injury or even
                  death to a developing fetus. When pregnancy is detected, consult
                  your healthcare professional as soon as possible.
 Alpha methyldopa (Aldomet)* may produce a greater drop in blood
                  pressure when you're in an upright position (standing or walking), and
                  it may make you feel weak or faint if the pressure has been lowered
                  too far. This drug may also cause drowsiness or sluggishness, dryness
                  of the mouth, fever or anemia. Male patients may experience
                  impotence. If this side effect persists, your doctor may have to change
                  the drug dosage or use another medication.
Possible Side    Clonidine (Catapres)*, guanabenz (Wytensin)* or guanfacine (Tenex)*
Effects of        may produce severe dryness of the mouth, constipation or
                  drowsiness. If you're taking any of these drugs, don't stop suddenly
Central           because your blood pressure may rise quickly to dangerously high
                  levels.
Agonists and     Hydralazine (Apresoline)* may cause headaches, swelling around the
                  eyes, heart palpitations or aches and pains in the joints. Usually none
Vasodilators      of these symptoms are severe, and most will go away after a few
                  weeks of treatment. This drug isn't usually used by itself.
                 Minoxidil (Loniten)* is a potent drug that's usually used only in
                  resistant cases of severe high blood pressure. It may cause fluid
                  retention (marked weight gain) or excessive hair growth.
 Palpitations
Possible        Swollen ankles
Calcium
                Constipation
Channel
                Headache
Blocker Side
Effects         Dizziness
Normal BP      Elevated BP      Stage 1 HTN                   Stage 2 HTN
              140/90 mmHg
             Hg         mmHg
             Promote        Initiate         Is estimated 10 year CVD      Initiate lifestyle
             optimal        lifestyle        < 10%? If no, initiate        changes and BP
             lifestyle      changes          lifestyle changes and re-     lowering medication.
             habits                          eval in 3-6 months.

             Re-evaluate    Re-evaluate in   Is estimated 10 year CVD      Re-evaluate in one
How to       in one year.   3-6 months.      > 10 %? If yes, initiate
                                             lifestyle changes and BP
                                                                           month.

manage HTN                                   lowering medication and
                                             re-evaluate in one month.

                                             Eval in 1 month- is BP goal   If BP goal not met,
                                             met? Why not? Increase        why not & increase
                                             med & see monthly til BP      meds. See monthly
                                             at goal. When BP at goal,     til BP at goal. When
                                             evaluate every 3-6            goal met, eval every
                                             months.                       3-6 months.
How to assess                 Scores: Low Risk  20%
 Aggressive BP treatment in the elderly – does it
Treatment     put them at too high risk?
issues:      HTN treatment may slow cognitive decline.
Clinical Frailty
Scale

               Athanase Benetos. Circulation Research. Hypertension Management
               in Older and Frail Older Patients, Volume: 124, Issue: 7, Pages: 1045-
               1060, DOI: (10.1161/CIRCRESAHA.118.313236)                               © 2019 American Heart Association, Inc.
Decisional
Algorithm for the
management of
Hypertension
in patients
aged 80 + years

             Athanase Benetos. Circulation Research. Hypertension Management
             in Older and Frail Older Patients, Volume: 124, Issue: 7, Pages: 1045-
             1060, DOI: (10.1161/CIRCRESAHA.118.313236)                               © 2019 American Heart Association, Inc.
 2004 Kdoqi – HTN pre-dialysis is >140/90 pre-dialysis and HTN
                  post-dialysis is >130/80
                 However dialysis BP readings are often taken without looking at
                  appropriate technique (cuff size, arm placement, clothing, etc).
Do we use the    BP readings taken in dialysis are not taken for diagnostic readings
same HTN          but to monitor cardiovascular stability before, during and
                  immediately for evaluating the dialysis treatment.
goals for        Potential factors leading to inaccurate dialysis bp readings: white
                  coat syndrome, limited time for patients to relax, cannulation fear,
dialysis          unknown validity of the bp devices attached to the hemodialysis
                  machine, medication adherence or holding medications pre-
patients?         dialysis, fluid volume excess, dialysis suite temperature.
                 ABPM is the “gold standard” method for diagnosing HTN in esrd.
                  This predicts all-cause and CV mortality better than peridialytic BP.
 HTN in dialysis should be defined on the basis of home BP or ABPM
                                         measurements.
Diagnosis of                            Home BP in HD: an average BP > 135/85 checked am/pm over 6 non-
                                         dialysis days (2 wk period). Measured in quiet room, seated with back
HTN in dialysis                          and arm supported, after 5 min rest with 2 bp checks per occasion
                                         taken 1-2 min apart.
patients                                Home BP in PD: average BP > 135/85 over 7 consecutive days with
                                         same technique as above.
( Sarafidis, Persu et al, 2017.
Hypertension in dialysis patients: a    ABPM in HD: average BP > 130/80 over 24-h monitoring, during a mid-
consensus document by the                weekday free of HD. If possible, extend to 44 hr, covering a whole mid
European Renal and Cardiovascular        week dialysis interval. PD is 24-h monitoring same BP.
Medicine (EURECA-m) working             For HD: no recommendations can be made on the basis of pre or post
group of the European Renal
Association – European Dialysis and
                                         dialysis BP. If no home or ABPM available, base the reading on office
Transplant Association (ERA-EDTA)        BP taken mid weekday free of HD, with average of 3 measurements
and the Hypertension and the             with 1-2 min intervals obtained in sitting position with 5 min of quiet
Kidney working group of the              rest.
European Society of Hypertension        The threshold of office BP > 140/90 can be used as the HTN diagnosis
(ESH).
                                         of HTN in HD/PD patients.
 Sodium and volume overload
Main
                                                   Increase arterial stiffness
mechanisms of                                      Activation of the sympathetic nervous system
HTN in dialysis                                    Activation of the renin-angiotensin-aldosterone system
patients                                           Endothelial dysfunction (i.e imbalance between endothelium-
( Sarafidis, Persu et al, 2017. Hypertension in
dialysis patients: a consensus document by          derived vasodilators and vasoconstriction)
the European Renal and Cardiovascular
Medicine (EURECA-m) working group of the           High prevalence of sleep apnea
European Renal Association – European
Dialysis and Transplant Association (ERA-
EDTA) and the Hypertension and the Kidney
                                                   Use of Erythropoietin-stimulating agents
working group of the European Society of
Hypertension (ESH).
 >172,000 patients followed for median 25 months. 43% of the patients died
                                               during the followup. Criteria: 4-6 months after HD initiation using FMC data
                                               from 2001-2012.
                                              Identified a general trend: increased mortality with either high pre-HD SBP
                                               and peridialytic SBP increase OR low pre-HD SBP and peridalytic SBP decline.
Association of all-cause                      Identified 4 distinct pre-HD SBP levels: 110, 130, 160, 180 mmHg
mortality with pre-                           Patients with pre-HD SBP levels of 110 that had an increase of SBP was
dialysis systolic blood                        associated with better survival. Decreased SBP associated with increased
                                               mortality.
pressure and it
peridialytic change in                        Patients with pre-HD SBP 130 (normal) that had SBP decrease was not
                                               associated with increased mortality. SBP increase was associated with
chronic hemodialysis                           decreased mortality.
patients                                      Patients with 160/180 pre-HD SBP that had SBP increase was associated with
(Zhange, Preciado, Wang et al, 2020.           increased mortality. SBP decrease was associated with decreased mortality.
Nephrology Dialysis Transplantation, 1-7.)
                                              Generally, SBP declines by >30mmHg or any SBP increase is associated with
                                               higher mortality.
                                              Patient with high pre-HD SBP and increased SBP may suffer from chronic FVO
                                               and vascular stiffness. These patients might benefit from more intensive fluid
                                               removal.
 Achievement of individual patients’ dry weight
                Minimization of inter- and intradialytic sodium gain
                Restriction of sodium intake to
 Beta Blockers (lol): Carvedilol reduced mortality compared with
                  placebo in HD patients with dilated cardiomyopathy
                 Thrice weekly Atenolol reduced CV events c/w thrice weekly
                  lisinopril in HD pts with HTN and LVH.
                 ACEi (pril): Fosinopril did not reduce CV events & mortality c/w
Pharmacologic     placebo in HD patients with LVH.
                 ARBS (sartan): Losartan/valsartan/candesartan reduced CV events
HTN               & mortality treatment not including ACEi/ARBs in HD patients.
Treatment        Olmesartan did not reduce CV events or mortality c/w treatment
                  not including ACEi/ARBs in HD patient with HTN.
                 CCBs (pine): Amlodipine reduced CV events c/w placement in HD
                  patients with HTN.
                 MRAs: Spironolactone may reduce CV events & mortality c/w no
                  additional treatment or placebo in HD and PD.
 ACOG has recommended treating pregnant patients as chronically
                                          hypertensive according to recently changed criteria from the
                                          American College of Cardiology and the American Heart
                                          Association, which call for classifying blood pressure into the
                                          following categories:
                                         Normal. Systolic BP less than 120 mm Hg; diastolic BP less than
HTN in                                    80 mm Hg.
Pregnancy                                Elevated. Systolic BP greater than or equal to 120-129 mm Hg;
                                          diastolic BP greater than 80 mm Hg.
ACOG 2019 guidelines for Hypertension
Treatment in Pregnancy
                                         Stage 1 hypertension. Systolic BP, 130-139 mm Hg; diastolic BP,
                                          80-89 mm Hg.
                                         Stage 2 hypertension. Systolic BP greater than or equal to 140
                                          mm Hg; diastolic BP greater than or equal to 90 mm Hg.
HTN           Pregnant women with chronic hypertension also should receive
               low-dose aspirin between 12 weeks and 28 weeks of gestation.
Treatment     Antihypertensive therapy should be initiated for women with
Guidelines     persistent chronic hypertension at systolic pressure of 160 mm Hg
               or higher and/or diastolic pressure of 110 mm Hg or higher.
during        Consider treating patients at lower blood pressure (BP) thresholds
Pregnancy      depending on comorbidities or underlying impaired renal function.
Drug Therapy
for
Hypertension
in Pregnancy
KDIGO Clinical
Practice
Guidelines on
the
management
of BP in
Chronic Kidney
Disease
January 2020
 1. Lose weight: By far the most effective means of reducing elevated blood
                  pressure is to lose weight. And it doesn't require major weight loss to make a
                  difference. Even losing as little as 10 pounds can lower your blood pressure.
                 2. Read labels : Americans eat far too much dietary sodium, up to three times the
                  recommended total amount, which is 1,500 milligrams (mg) daily for individuals
                  with high blood pressure. It doesn't take much sodium to reach that 1,500-mg
                  daily cap — just 3/4 of a teaspoon of salt. There's half of that amount of sodium in
                  one Egg McMuffin breakfast sandwich. Weed out high-sodium foods by reading
                  labels carefully. "It is very difficult to lower dietary sodium without reading labels,
                  unless you prepare all of your own food. Beware of the "salty six," common foods
                  where high amounts of sodium may be lurking: breads and rolls, cold cuts and
                  cured meats, pizza, poultry, soup, sandwiches.
                 3. Get moving: It doesn't take much exercise to make a difference in your health.
Small Changes     Aim for a half-hour at least five days a week. "Make sure you're doing something
                  you love, or it won't stick." "For some that means dancing; for others, biking or
to lower BP       taking brisk walks with a friend." Even everyday activities such as gardening can
                  help.
                 4. Pump some iron: Add some weight lifting to your exercise regimen to help
                  lose weight and stay fit. Women lose muscle mass steadily as we age, and weight
                  lifting is an often-overlooked part of an exercise plan.
                 5. Limit alcohol to one drink per day: Drinking too much, too often, can increase
                  your blood pressure, so practice moderation.
                 6. Relieve stress with daily meditation or deep breathing sessions: Stress
                  hormones constrict your blood vessels and can lead to temporary spikes in blood
                  pressure. In addition, over time, stress can trigger unhealthy habits that put your
                  cardiovascular health at risk. These might include overeating, poor sleep, and
                  misusing drugs and alcohol. For all these reasons, reducing stress should be a
                  priority if you're looking to lower your blood pressure.
 Big Breakfast with Hotcakes (2100 mg sodium): 87% of
                   recommended sodium
                  6-Piece Buttermilk Crispy Tenders (2090 mg sodium): 87% of
                   recommended sodium
                  20-Piece Chicken McNuggets (1680mg sodium): 70% of the
                   recommended sodium
MCDonalds         Double Quarter Pounder with Cheese (1300mg sodium): 54% of
                   the recommended sodium
Saltiest Foods    The average adult consumes 3,400 mg of sodium per day
from AHA           according to the Mayo Clinic. The primary cause of the excessive
                   daily intake of sodium is processed and preserved foods. These are
                   the menu offerings in America's fast-food restaurants like
                   McDonald's.
 59 y/o female with Lupus with CKD stage 4, HTN.
              April 2018 -- Uncontrolled hypertension (153/96) increased Serum
               Creatinine (2.53 mg/dl) and proteinuria (UACR 1289).
              Further medication adjustment, added chlorthalidone 12.5 – 25mg
               that patient adjusted daily based on blood pressure and
Case Study     edema/weight gain to keep SBP around 115-125.
              Serum Creatinine 2.37 – 2.32 mg/dl (eGFR 21-22) now all of 2019
               with UACR decreased to 681 and SBP maintained in the 115-125
               range.
Thank you and
any questions
You can also read